BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 20920516)

  • 1. Late hematologic toxicity following treatment of rattlesnake envenomation with crotalidae polyvalent immune Fab antivenom.
    Ruha AM; Curry SC; Albrecht C; Riley B; Pizon A
    Toxicon; 2011 Jan; 57(1):53-9. PubMed ID: 20920516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent hemorrhage after western diamondback rattlesnake envenomation treated with crotalidae polyvalent immune fab (ovine).
    Fazelat J; Teperman SH; Touger M
    Clin Toxicol (Phila); 2008 Nov; 46(9):823-6. PubMed ID: 18608290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent coagulopathy and thrombocytopenia in children treated with crotalidae polyvalent immune fab: a case series.
    Miller AD; Young MC; DeMott MC; Ly BT; Clark RF
    Pediatr Emerg Care; 2010 Aug; 26(8):576-82. PubMed ID: 20693856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed hematologic toxicity following rattlesnake envenomation unresponsive to crotalidae polyvalent antivenom.
    Bailey AM; Justice S; Davis GA; Weant K
    Am J Emerg Med; 2017 Jul; 35(7):1038.e1-1038.e2. PubMed ID: 28259369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent coagulopathy with delayed significant bleeding after crotaline envenomation.
    O'Brien NF; DeMott MC; Suchard JR; Clark RF; Peterson BM
    Pediatr Emerg Care; 2009 Jul; 25(7):457-9. PubMed ID: 19606002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous IV Crotalidae Polyvalent Immune Fab (Ovine) (FabAV) for selected North American rattlesnake bite patients.
    Bush SP; Seifert SA; Oakes J; Smith SD; Phan TH; Pearl SR; Reibling ET
    Toxicon; 2013 Jul; 69():29-37. PubMed ID: 23474267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservative management of delayed, multicomponent coagulopathy following rattlesnake envenomation.
    Camilleri C; Offerman S; Gosselin R; Albertson T
    Clin Toxicol (Phila); 2005; 43(3):201-6. PubMed ID: 15902796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Southern Pacific Rattlesnake bite: a unique clinical challenge.
    Wasserberger J; Ordog G; Merkin TE
    J Emerg Med; 2006 Oct; 31(3):263-6. PubMed ID: 16982358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hypersensitivity reactions associated with administration of crotalidae polyvalent immune Fab antivenom.
    Cannon R; Ruha AM; Kashani J
    Ann Emerg Med; 2008 Apr; 51(4):407-11. PubMed ID: 18191286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crotalidae polyvalent immune Fab (ovine) antivenom is effective in the neutralization of South American viperidae venoms in a murine model.
    Richardson WH; Tanen DA; Tong TC; Betten DP; Carstairs SD; Williams SR; Cantrell FL; Clark RF
    Ann Emerg Med; 2005 Jun; 45(6):595-602. PubMed ID: 15940091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory thrombocytopenia despite treatment for rattlesnake envenomation.
    Gold BS; Barish RA; Rudman MS
    N Engl J Med; 2004 Apr; 350(18):1912-3; discussion 1912-3. PubMed ID: 15115843
    [No Abstract]   [Full Text] [Related]  

  • 12. Crotalidae polyvalent immune Fab: in patients with North American crotaline envenomation.
    Keating GM
    BioDrugs; 2011 Apr; 25(2):69-76. PubMed ID: 21443271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial postmarketing experience with crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation.
    Ruha AM; Curry SC; Beuhler M; Katz K; Brooks DE; Graeme KA; Wallace K; Gerkin R; Lovecchio F; Wax P; Selden B
    Ann Emerg Med; 2002 Jun; 39(6):609-15. PubMed ID: 12023703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial experience with Crotalidae polyvalent immune Fab (ovine) antivenom in the treatment of copperhead snakebite.
    Lavonas EJ; Gerardo CJ; O'Malley G; Arnold TC; Bush SP; Banner W; Steffens M; Kerns WP
    Ann Emerg Med; 2004 Feb; 43(2):200-6. PubMed ID: 14747809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent, persistent, or late, new-onset hematologic abnormalities in Crotaline snakebite.
    Seifert SA; I Kirschner R; Martin N
    Clin Toxicol (Phila); 2011 Apr; 49(4):324-9. PubMed ID: 21563909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crotalidae polyvalent immune Fab (ovine) antivenom is efficacious for envenomations by Southern Pacific rattlesnakes (Crotalus helleri).
    Bush SP; Green SM; Moynihan JA; Hayes WK; Cardwell MD
    Ann Emerg Med; 2002 Dec; 40(6):619-24. PubMed ID: 12447339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Report of two cases: Rattlesnake venom-induced thrombocytopenia.
    Odeleye AA; Presley AE; Passwater ME; Mintz PD
    Ann Clin Lab Sci; 2004; 34(4):467-70. PubMed ID: 15648790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late, new-onset thrombocytopenia in a rattlesnake envenomation treated with a Fab antivenom.
    Seifert SA; Cano DN
    Clin Toxicol (Phila); 2013 Nov; 51(9):911-2. PubMed ID: 24066732
    [No Abstract]   [Full Text] [Related]  

  • 19. Late hemotoxicity following North American rattlesnake envenomation treated with crotalidae immune F(ab')
    Spyres MB; Padilla GK; Gerkin RD; Hoyte CO; Wolk BJ; Ruha AM;
    Clin Toxicol (Phila); 2022 Jul; 60(7):838-842. PubMed ID: 35261320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crotalidae polyvalent immune Fab for the treatment of pediatric crotaline envenomation.
    Goto CS; Feng SY
    Pediatr Emerg Care; 2009 Apr; 25(4):273-9; quiz 280-2. PubMed ID: 19369845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.